This quantitative imaging approach demonstrated that the CCL5/collagen IV ratio has a significant prognostic value for disease-free survival in patients with breast cancer, providing valuable information for tailoring patient-specific therapeutic strategies [110]. Here, CCL5 is linked to breast carcinoma.